Solventum will host a conference call today, Nov. 6, at 4:30 p.m. Eastern Time to discuss its third quarter financial results and provide an update on its business. The conference call can be accessed ...

*Data in the schedule above is intentionally rounded to the nearest million and, therefore, may not sum. 2 Constant currency represents the change in net sales absent the impact on sales from foreign ...

(Reuters) - 3M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products. Minnesota-based Solventum ...

17/12 Solventum publie les recommandations d'un panel international et multidisciplinaire d'experts en chirurgie et en soins des plaies sur l'utilisation clinique de la thérapie par pression négative ...

Solventum is a healthcare company operating in four segments and serving end markets that management believes have a market size of at least $93 billion and are growing at a rate of 4%- 6%. The table ...

ST. PAUL, Minn., Nov. 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its Board of Directors has approved a share repurchase program, which authorizes the Company to purchase up to $1 ...

Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space, a part of the broader regenerative tissue matrices category within acute care settings, a $900 million ...

On Thursday, Solventum (NYSE:SOLV) hosted its 2025 Investor Day, during which it outlined its strategic priorities, its business segments, and its long-range plan (LRP) to drive growth and value ...

20/11 Solventum acquiert Acera Surgical et lance un programme de rachat d'actions d'un milliard de dollars MT 20/11 Solventum annonce un accord pour l'acquisition d'Acera Surgical RE 20/11 Solventum ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Solventum Corporation ( (SOLV)) just ...

NEW YORK - Solventum Corporation (NYSE:SOLV), a medical technology company with a market capitalization of $12.38 billion and current stock price of $72, announced on Friday it has commenced tender ...

NEW YORK - Solventum (NYSE:SOLV), a healthcare company with a market capitalization of $12.61 billion, announced Monday the pricing terms for its previously announced tender offers to purchase up to ...